Secretory symptoms from metastatic adrenal cortical carcinoma responding to octreotide. Issue 834 (April 1995)

• Record Type: Journal Article
• Authors: Pandha, H. S.; Harrington, K.; Saini, S.; Lynn, J.; Peters, M.; Waxman, J.
• Is Part Of: Postgraduate medical journal. Volume 71:Issue 834(1995)
• Page Start: 229
• Page End: 230
• Publication Date: 1995-04
• Subjects: Medicine -- Periodicals; 610
• DOI: 10.1136/pgmj.71.834.229
• Languages: English
• ISSNs: 0032-5473

Abstract

Abstract : The prognosis of patients with metastatic adrenal cortical carcinoma is poor, and their disabling symptoms are usually unresponsive to conventional therapy. A patient with Cushing's syndrome secondary to a secretory adrenal cortical carcinoma was treated with octreotide, endocrine therapy and chemotherapy having failed. Treatment led to a dramatic relief of her symptoms with a fall in corticosteroid secretion. Somatostatin analogue therapy for this tumour should be encouraged in view of the lack of alternative palliative treatment.